Health-related quality of life in multiple sclerosis: effects of natalizumab. - Wikidata - awgldk - TriplyDB

Health-related quality of life in multiple sclerosis: effects of natalizumab.

Health-related quality of life in multiple sclerosis: effects of natalizumab.

http://www.wikidata.org/entity/Q34662511

about

Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients Natalizumab for relapsing remitting multiple sclerosis Integrin-based therapeutics: biological basis, clinical use and new drugs Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations Development of oral immunomodulatory agents in the management of multiple sclerosis Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study The effect of rhythmic-cued motor imagery on walking, fatigue and quality of life in people with multiple sclerosis: A randomised controlled trial.Voice-related quality of life in patients with multiple sclerosis.Natalizumab: a review of its use in the management of relapsing-remitting multiple sclerosis.Using existing data to identify candidate items for a health state classification system in multiple sclerosis.Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis.Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosis.Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis.Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study.Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency in people with multiple sclerosis: a summary of a Cochrane systematic review.Integrin targeted therapeutics.Vision in a phase 3 trial of natalizumab for multiple sclerosis: relation to disability and quality of life Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial.Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study Natalizumab therapy for multiple sclerosis Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?Treating multiple sclerosis with monoclonal antibodies.Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.Natalizumab for the treatment of relapsing multiple sclerosis.Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.Quality of life in multiple sclerosis: effects of current treatment options.Vitamin D as an early predictor of multiple sclerosis activity and progression.Progressive multifocal leukoencephalopathy and natalizumab.Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence.Clinical biomarkers in multiple sclerosis.

P2860

Q24202111-35F3CADF-2CBF-4FBF-9A32-A787C421CC99 Q24202967-45E9C754-C1F0-4791-A51D-86DCD8FA3F8D Q24235861-50E6E5FD-8306-4F33-BCFB-6B60D6C60ECA Q26773026-4950AA5E-2023-461E-85D3-1BB5C3077090 Q26776157-1A925712-F7E3-4B5E-AEF0-D815BF24609A Q26822611-759FDD3F-30F5-4A55-A0F3-F6F12A725E19 Q27009769-99CD268C-44A0-4F8F-9662-FA728A99895D Q28388704-D5BA1E47-58AC-4D30-9AA6-F8292C94FB1F Q28730321-B693894C-2BFB-4A5C-9B27-C650F137309C Q30386624-1CDE0E9A-CB82-44A3-B481-4B5B5CC0988D Q30462390-1D56EFD2-764B-4E14-81FA-02D368232573 Q30659100-866E2041-2BEC-49B3-A0B7-9BEA2D52FB75 Q30715052-4D42C364-DE50-468C-BE80-A68B8AD7EB36 Q31038347-E3AB7D87-F760-4AA2-8E2D-35C12B6401B6 Q33573208-4CA2B95C-E571-48D2-821C-E964ECDFED02 Q33598958-F8D22EE9-4EBA-48C7-B37D-6567C5FB1C52 Q33825885-D2787023-6F6F-4608-A8F7-ED8EB7F0365A Q34344447-44CADE82-FB34-4982-9F05-620235557B3F Q34656844-3469D5BC-7CC9-43CA-B2B2-C69BD0A5ED9A Q34656851-FFF6C72D-A61D-4C67-9EFB-D365D0D59BF3 Q34777862-B444FE0F-4DD7-439A-A54A-C87AEAE2779C Q34912684-2A6232C0-5CE5-43C4-B149-0788E1B56903 Q35111163-A061C8B0-CEF1-411C-8CDB-CDA567A0AFFC Q35194642-3CE2D38F-0A6A-45D2-8FA1-4A5A612B72BF Q35205472-FC342D5C-CC5C-47E1-8116-F94B82298084 Q36293816-0667ABEC-6193-4789-86FE-2BBDD5E6509C Q36526965-9697E6F5-88C8-4D70-AC4E-A563FD0C7E48 Q36568666-7E893780-AAFB-4B50-B6FF-CBA3C4C040C5 Q36831616-2C56FFD2-B14B-4B42-AF60-9E059513C09E Q37111904-B3756FCF-47EF-4B17-8002-0D810DE95E77 Q37200093-AD6B96FD-6073-4CFD-B30E-2962D213EE61 Q37290643-6BDAB456-D911-4448-8619-1E1823214936 Q37395002-D5DC2EEC-6418-47C4-99E6-A1EFE086CBFD Q37442396-B08E8246-AB77-43A2-8E01-68DCA9E56058 Q37668551-E2D90026-EAD9-4BAE-8ECC-2B2AB795F2BF Q37710122-267CF8E6-47B4-4CA9-B865-13155E00F50B Q37723877-6B67261C-DF08-4FE1-8EBB-A3B8115C6A66 Q37885823-05810BC5-06EF-4D96-9BBD-96D8FEC48C65 Q37976344-B21C848A-498F-42AC-940C-F16BCECA1837 Q38088728-D605DF61-8F4D-4B5B-A684-436CABCF1E30

P2860

Health-related quality of life in multiple sclerosis: effects of natalizumab.

http://www.wikidata.org/entity/Q34662511

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@ast

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@en

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@nl

type

label

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@ast

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@en

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@nl

prefLabel

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@ast

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@en

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@nl

P1433

Q34662511-4C442664-C130-4704-9C37-79BA7298BDE2

P1476

Q34662511-D66DF35C-B77D-4784-933B-E954482DC7EE

P2093

Q34662511-04A47254-1133-477F-9958-98C2759C4EA2

Q34662511-11A8A2DA-B2EA-4408-A802-E305B34FFCD2

Q34662511-3FD35796-6551-4375-B3EC-1F14530E9DF3

Q34662511-45E6173A-71FC-448D-BE08-A15C75F73A60

Q34662511-493CF08A-5A39-4F8D-856F-5E6D51717BF1

Q34662511-51A1103C-33C6-4D25-A2F9-1F9CB5731191

Q34662511-53EECBF7-B579-4238-ADA6-C45E3C619329

Q34662511-541CE412-FF84-493B-BE15-8CF1EC0D305D

Q34662511-8C741B29-99EA-4C2A-88EF-147685E296BB

Q34662511-8CA66D2B-5875-46E3-8026-DB751173ED6E

P304

Q34662511-AB9ECF49-B5BF-4AB4-A362-AB9492D545F2

P31

Q34662511-099D8A6D-912A-43FB-B52A-D62A3DDA15C2

P356

Q34662511-49CB9F2D-F6DD-4459-A425-60452D7CC8B0

P433

Q34662511-B4E8FBEF-D53D-461A-A867-AAF5124407CF

P478

Q34662511-C2561979-F6F8-42FC-820A-DB467244242B

P50

Q34662511-371EFF2D-0080-4DEA-8492-974F6736BC71

Q34662511-4065F820-BE56-4F02-8427-33D1563A1C54

Q34662511-5F972A6F-884D-4EDD-B536-85FE330AA5DF

Q34662511-6D24A210-3796-464F-BFCB-FEBB06AB060F

Q34662511-71527401-4EB1-4330-B849-18A8FDB4C6C9

Q34662511-9419BAFE-D4FF-4542-99F5-A83025B04A9C

Q34662511-A9FA8744-D94A-4F1C-BA24-244C16E9580F

Q34662511-E7DB2E7D-D015-4BFB-92FC-2B77343D978C

P577

Q34662511-746A06F1-7569-4450-A528-E06953CCD1CB

P698

Q34662511-AB745CA7-2562-43D0-A4E5-67A897D69B71

P921

Q34662511-17E371D4-E16F-4FCB-9BE0-CA30C6E5E73C

Q34662511-CC279234-8BFC-4EFA-9F63-4BFD2268FE6E

P356

P1433

Annals of Neurology

P1476

Health-related quality of life in multiple sclerosis: effects of natalizumab.

@en

P2093

AFFIRM and SENTINEL Investigators

http://www.w3.org/2001/XMLSchema#string

Andrzej Wajgt

http://www.w3.org/2001/XMLSchema#string

Chris H Polman

http://www.w3.org/2001/XMLSchema#string

Christian Confavreux

http://www.w3.org/2001/XMLSchema#string

Daniel R Wynn

http://www.w3.org/2001/XMLSchema#string

David H Miller

http://www.w3.org/2001/XMLSchema#string

Deborah Miller

http://www.w3.org/2001/XMLSchema#string

Ernst-Wilhelm Radue

http://www.w3.org/2001/XMLSchema#string

Frances Lynn

http://www.w3.org/2001/XMLSchema#string

Fred D Lublin

http://www.w3.org/2001/XMLSchema#string

P304

335-346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.21163

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Bianca Weinstock-Guttman

Michael Hutchinson

Gavin Giovannoni

Peter A Calabresi

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17696126

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

multiple sclerosis